Treatment for radiation retinopathy of uveal melanoma undergone radiotherapy: the current situation
10.3760/cma.j.issn.1005-1015.2018.05.025
- VernacularTitle:葡萄膜黑色素瘤放射治疗后继发放射性视网膜病变的干预治疗研究现状
- Author:
Mengxi CHEN
1
;
Yueming LIU
;
Wenbin WEI
Author Information
1. 100730,首都医科大学附属北京同仁医院北京同仁眼科中心眼内肿瘤诊治研究北京市重点实验室
- Keywords:
Uveal neoplasms/radiotherapy;
Radiotherapy/adverse effects;
Retinal diseases/therapy;
Review
- From:
Chinese Journal of Ocular Fundus Diseases
2018;34(5):515-518
- CountryChina
- Language:Chinese
-
Abstract:
Radiotherapy is the prior treatment for uveal melanoma,but a major problem confronted most of the patients is radiation retinopathy,which accompanied with severe visual loss and secondary enucleation potential.There is no optium choice and normative strategy so far,the intraocular melanoma society has focused on application of anti-vascular endothelial growth factor drugs injection and glucocorticoids.This article reviews a series of potential managements for radiation retinopathy and its further stage.
